Cardiovascular disease remains the leading cause of death in patients with diabetes.
Cardiovascular disease in diabetes is multifactorial, and control of the cardiovascular risk …

Diabetes mellitus predisposes affected individuals to a significant spectrum of
cardiovascular complications, one of the most debilitating in terms of prognosis is heart …

The American Diabetes Association and the European Association for the Study of Diabetes
convened a panel to update the prior position statements, published in 2012 and 2015, on …

Abstract The American Diabetes Association and the European Association for the Study of
Diabetes convened a panel to update the prior position statements, published in 2012 and …

Background: Clinicians and patients need updated evidence on the comparative
effectiveness and safety of diabetes medications to make informed treatment choices …

Aims To determine the effect of the glucagon‐like peptide‐1 analogue liraglutide on left
ventricular function in chronic heart failure patients with and without type 2 diabetes …

Cardiovascular disease (CVD) is a major challenge in the management of type 2 diabetes
mellitus. Glucose-lowering agents that reduce the risk of major cardiovascular events would …

Type 2 diabetes mellitus (T2DM) is common in patients with heart failure (HF) and
associated with considerable morbidity and mortality. Significant advances have recently …

Type 2 diabetes mellitus is a growing global public health problem, the prevalence of which
is projected to increase in the succeeding decades. It is potentially associated with many …

As a family of hormones with pleiotropic effects, natriuretic peptide (NP) system includes
atrial NP (ANP), B-type NP (BNP), C-type NP (CNP), dendroaspis NP and urodilatin, with NP …